{"id":2442,"date":"2021-03-30T11:56:50","date_gmt":"2021-03-30T10:56:50","guid":{"rendered":"https:\/\/www.almacgroup.com\/diagnostics\/?post_type=diagnostic_resource&#038;p=2442"},"modified":"2021-09-22T14:04:11","modified_gmt":"2021-09-22T13:04:11","slug":"the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials","status":"publish","type":"diagnostic_resource","link":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/","title":{"rendered":"The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials"},"content":{"rendered":"\n<div class=\"wp-block-image\"><figure class=\"alignright size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/03\/leeona.png\" alt=\"\" class=\"wp-image-1208\" width=\"166\" height=\"162\"\/><figcaption>Featured Speaker<br><strong>Leeona Galligan<br><\/strong>VP UK Operations<\/figcaption><\/figure><\/div>\n\n\n\n<p>In this talk, Almac Diagnostic Services VP of UK Operations, Dr Leeona Galligan, will explore the realities of running next-generation sequencing (NGS) liquid biopsy panels in biomarker-driven clinical trials from a CLIA laboratory diagnostic provider viewpoint.<\/p>\n\n\n\n<p>We will discuss the opportunities and challenges of NGS liquid biopsy panels and the critical steps involved in ensuring that they are ready for stratification use within clinical trials, as demonstrated by a biotech case study.<\/p>\n\n\n\n<p>Almac Diagnostic Services has experience in both the development &amp; analytical validation of blood-based molecular biomarkers so that the assays are both robust and compliant with appropriate global regulatory frameworks for prospective clinical trial stratification.<\/p>\n\n\n\n<p><strong>What You Will Learn<\/strong><\/p>\n\n\n\n<ul><li>Key aspects of running NGS liquid biopsy panels in biomarker-driven clinical trials<\/li><li>Challenges of demonstrating adequate analytical performance of the panel<\/li><li>The importance of adequate specimen collection and stabilisation<\/li><li>Data analysis pipeline considerations for liquid biopsy panels<\/li><\/ul>\n\n\n\n<div style=\"height:56px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<!--[if lte IE 8]>\n<script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/v2-legacy.js\"><\/script>\n<![endif]-->\n<script charset=\"utf-8\" type=\"text\/javascript\" src=\"\/\/js.hsforms.net\/forms\/v2.js\"><\/script>\n<script>\n  hbspt.forms.create({\n\tregion: \"na1\",\n\tportalId: \"742105\",\n\tformId: \"1ca60652-3496-49b7-b15d-548d6a6965ac\"\n});\n<\/script>\n","protected":false},"featured_media":0,"template":"","diagnostics_type":[474],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.2 (Yoast SEO v23.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials - Diagnostic Services<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials\" \/>\n<meta property=\"og:description\" content=\"In this talk, Almac Diagnostic Services VP of UK Operations, Dr Leeona Galligan, will explore the realities of running next-generation sequencing (NGS) liquid biopsy panels in biomarker-driven clinical trials from a CLIA laboratory diagnostic provider viewpoint. We will discuss the opportunities and challenges of NGS liquid biopsy panels and the critical steps involved in ensuring [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Diagnostic Services\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-22T13:04:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/03\/leeona.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/\",\"url\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/\",\"name\":\"The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials - Diagnostic Services\",\"isPartOf\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/03\/leeona.png\",\"datePublished\":\"2021-03-30T10:56:50+00:00\",\"dateModified\":\"2021-09-22T13:04:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#primaryimage\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/03\/leeona.png\",\"contentUrl\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/03\/leeona.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/almacgroup.jp\/diagnostics\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#website\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/\",\"name\":\"Diagnostic Services\",\"description\":\"Just another Almac Core Sites site\",\"publisher\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.almacgroup.com\/diagnostics\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#organization\",\"name\":\"Almac Group Ltd\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg\",\"contentUrl\":\"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg\",\"width\":643,\"height\":296,\"caption\":\"Almac Group Ltd\"},\"image\":{\"@id\":\"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials - Diagnostic Services","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/","og_locale":"en_GB","og_type":"article","og_title":"The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials","og_description":"In this talk, Almac Diagnostic Services VP of UK Operations, Dr Leeona Galligan, will explore the realities of running next-generation sequencing (NGS) liquid biopsy panels in biomarker-driven clinical trials from a CLIA laboratory diagnostic provider viewpoint. We will discuss the opportunities and challenges of NGS liquid biopsy panels and the critical steps involved in ensuring [&hellip;]","og_url":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/","og_site_name":"Diagnostic Services","article_modified_time":"2021-09-22T13:04:11+00:00","og_image":[{"url":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/03\/leeona.png"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/","url":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/","name":"The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials - Diagnostic Services","isPartOf":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/#website"},"primaryImageOfPage":{"@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/03\/leeona.png","datePublished":"2021-03-30T10:56:50+00:00","dateModified":"2021-09-22T13:04:11+00:00","breadcrumb":{"@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#primaryimage","url":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/03\/leeona.png","contentUrl":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/03\/leeona.png"},{"@type":"BreadcrumbList","@id":"https:\/\/almacgroup.jp\/diagnostics\/diagnostic-resource\/the-realities-of-running-next-generation-sequencing-liquid-biopsy-panels-in-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/almacgroup.jp\/diagnostics\/"},{"@type":"ListItem","position":2,"name":"The Realities of Running Next-Generation Sequencing Liquid Biopsy Panels in Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/www.almacgroup.com\/diagnostics\/#website","url":"https:\/\/www.almacgroup.com\/diagnostics\/","name":"Diagnostic Services","description":"Just another Almac Core Sites site","publisher":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.almacgroup.com\/diagnostics\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/www.almacgroup.com\/diagnostics\/#organization","name":"Almac Group Ltd","url":"https:\/\/www.almacgroup.com\/diagnostics\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/","url":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg","contentUrl":"https:\/\/www.almacgroup.com\/diagnostics\/wp-content\/uploads\/sites\/3\/2020\/04\/almac-logo-with-strapline.jpg","width":643,"height":296,"caption":"Almac Group Ltd"},"image":{"@id":"https:\/\/www.almacgroup.com\/diagnostics\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/diagnostic_resource\/2442"}],"collection":[{"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/diagnostic_resource"}],"about":[{"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/types\/diagnostic_resource"}],"wp:attachment":[{"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/media?parent=2442"}],"wp:term":[{"taxonomy":"diagnostics_type","embeddable":true,"href":"https:\/\/almacgroup.jp\/diagnostics\/wp-json\/wp\/v2\/diagnostics_type?post=2442"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}